search
Back to results

High vs Low Dose Dexamethasone on Complications in the Immediate Postoperative Phase (DEX-GANZ)

Primary Purpose

Hip Dysplasia, Postoperative Complications

Status
Completed
Phase
Phase 4
Locations
Denmark
Study Type
Interventional
Intervention
Dexamethasone
Sponsored by
Rigshospitalet, Denmark
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Hip Dysplasia

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • planned unilateral periacetabular osteotomy
  • informed signed consent

Exclusion Criteria:

  • Chronic/ongoing (<30 days) use of glucocorticoids (except inhalation therapy)
  • ongoing (<30 days) use of immunosuppressive therapy
  • insulin dependent diabetes
  • pregnancy/breastfeeding
  • allergies toward study medication, or medication in the standard treatment
  • surgery cannot be performed

Sites / Locations

  • Rigshospitalet

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

Dexamethasone 48 mg

Dexamethasone 8 mg

Arm Description

Dexamethasone 48 mg pre-operative, single shot injection

Dexamethasone 8 mg pre-operative, single shot injection

Outcomes

Primary Outcome Measures

Number of Participants With Moderate to Severe Postoperative Pain
Moderate to severe pain (NRS > 3) in the post-anesthesia care unit (PACU)

Secondary Outcome Measures

Lenght of Stay, PACU
Total lenght of stay in PACU
Lenght of Stay, Hospital
Total lenght of stay, Hospital
Pain Scores, PACU
Differences between groups in maximal and average pain score during PACU stay. Pain scores are measured on a numeric rating scale (NRS), 0-10. 0 is no pain, 10 is worst pain imaginable.
Complications
Patients with complications requiring treatment the first 24 hours (PACU and ward)
Self Reported Postoperative Pain
Self-reported pain on a Numeric rating scale (NRS), NRS 0-10, 0 = no pain, 10= worst pain imaginable. Reported once daily, postoperative days 0 to 4
Number of Patients With Post Operative Nausea and Vomiting (PONV) Postoperative Days 0 to 4
Patients reporting PONV and/or receiving antiemetic medication on postoperative days 0 to 4
Number of Patients With Sleep Problems
Self-reported quality of sleep (days 0-4). Questionnaire. Results dichotomized to sleep problems (trouble falling asleep, frequent awakenings, no sleep) or no sleep problems.
Number of Patients With Feelings of Anxiety, Unrest and/or Sadness
Self-reported feelings of anxiety, unrest, sadness (days 0-4). Questionnaire
Number of Patients Readmitted to Hospital Within 30 Days
Any readmission within 30 days
Number of Patients With Wound Infections Within 30 Days
Any wound infections/complications

Full Information

First Posted
May 17, 2017
Last Updated
April 20, 2020
Sponsor
Rigshospitalet, Denmark
search

1. Study Identification

Unique Protocol Identification Number
NCT03161938
Brief Title
High vs Low Dose Dexamethasone on Complications in the Immediate Postoperative Phase
Acronym
DEX-GANZ
Official Title
High vs Low Dose Dexamethasone on Complications in the Immediate Postoperative Phase After Periacetabular (GANZ) Osteotomy
Study Type
Interventional

2. Study Status

Record Verification Date
April 2020
Overall Recruitment Status
Completed
Study Start Date
April 24, 2017 (Actual)
Primary Completion Date
August 20, 2019 (Actual)
Study Completion Date
August 20, 2019 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Rigshospitalet, Denmark

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The aim of this study is to investigate the effect of a single preoperative high-dose steroid injection on complications in the immediate postoperative phase after periacetabular osteotomy. Primary outcome is the proportion of patients who have moderate to severe postoperative pain in the post anaesthesia care unit. Secondary outcomes are organspecific complications in the post anaesthesia phase, pain and nausea the first 5 days, wound infection and readmissions the first 30 days after surgery. The investigators hypothesize that the frequency of moderate to severe pain and organspecific complications in the post anaesthesia care unit will be lower among patients receiving high dose dexamethasone. The investigators hypothesize, that there will be no difference in wound infections or readmissions.
Detailed Description
Post-surgery, patients are traditionally observed and treated in post-anesthesia care units (PACU) until they are discharged to the ward (or directly home) assessed by standardized international discharge criteria. The research project "Why in PACU?" (Rigshospitalet, Denmark), has since the beginning of 2016 systematically collected and analyzed procedure-related complications in the recovery phase. The complications include pain, nausea/vomiting, circulatory and respiratory problems, orthostatic intolerance and cognitive disorders. Common to all the above-mentioned post-operative problems are the possible links to the inflammatory response caused by the surgical trauma. Glucocorticoids can in this context be central for the reduction of acute postoperative organ dysfunctions, caused by the anti-inflammatory effect. In a number of different surgical procedures, single dose, pre-operative glucocorticoids have been shown to reduce post-operative nausea and vomiting (PONV), acute pain and need of opioids as well as accelerate the convalescence. Meta-analyses also showed that single-dose administration of glucocorticoids (methylprednisolone and dexamethasone) for surgical patients is safe as opposed to long-term treatment. The "Why in PACU?" database shows that 70 % of patients experience moderate to severe pain in the immediate postoperative phase. This is despite a multimodal analgesic regime with preoperative analgesics and local analgesic catheter in the surgical site. Opioids are frequently administered to relieve pain, resulting in sedation, risk of hypoxia and delaying mobilization. Patients having Ganz osteotomy are primarily young women with hipdysplasia, that are otherwise healthy. Lenght of stay is typically 5 days, due to pain and lack of mobilisation. In this study patients are randomized to either high dose (48 mg) or standard/low dose (8 mg) dexamethasone, administered preoperatively. The hypothese is that patients receiving high dose dexamethasone will experience less pain in the immediate postoperative course and receive less opioids. The study is not placebo-controlled since the positive effects of dexamethasone 8 mg on PONV have been shown in numerous trials, and is already being administered to all patients at the clinic. It would therefore not be ethically correct to withdraw from this practise.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hip Dysplasia, Postoperative Complications

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
64 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Dexamethasone 48 mg
Arm Type
Active Comparator
Arm Description
Dexamethasone 48 mg pre-operative, single shot injection
Arm Title
Dexamethasone 8 mg
Arm Type
Active Comparator
Arm Description
Dexamethasone 8 mg pre-operative, single shot injection
Intervention Type
Drug
Intervention Name(s)
Dexamethasone
Intervention Description
intravenous
Primary Outcome Measure Information:
Title
Number of Participants With Moderate to Severe Postoperative Pain
Description
Moderate to severe pain (NRS > 3) in the post-anesthesia care unit (PACU)
Time Frame
12 hours
Secondary Outcome Measure Information:
Title
Lenght of Stay, PACU
Description
Total lenght of stay in PACU
Time Frame
24 hours
Title
Lenght of Stay, Hospital
Description
Total lenght of stay, Hospital
Time Frame
1 week
Title
Pain Scores, PACU
Description
Differences between groups in maximal and average pain score during PACU stay. Pain scores are measured on a numeric rating scale (NRS), 0-10. 0 is no pain, 10 is worst pain imaginable.
Time Frame
12 hours
Title
Complications
Description
Patients with complications requiring treatment the first 24 hours (PACU and ward)
Time Frame
24 hours
Title
Self Reported Postoperative Pain
Description
Self-reported pain on a Numeric rating scale (NRS), NRS 0-10, 0 = no pain, 10= worst pain imaginable. Reported once daily, postoperative days 0 to 4
Time Frame
postoperative day 0 to 4, once a day
Title
Number of Patients With Post Operative Nausea and Vomiting (PONV) Postoperative Days 0 to 4
Description
Patients reporting PONV and/or receiving antiemetic medication on postoperative days 0 to 4
Time Frame
postoperative day 0 to 4, once a day
Title
Number of Patients With Sleep Problems
Description
Self-reported quality of sleep (days 0-4). Questionnaire. Results dichotomized to sleep problems (trouble falling asleep, frequent awakenings, no sleep) or no sleep problems.
Time Frame
4 days
Title
Number of Patients With Feelings of Anxiety, Unrest and/or Sadness
Description
Self-reported feelings of anxiety, unrest, sadness (days 0-4). Questionnaire
Time Frame
postoperative day 0 to 4, once a day
Title
Number of Patients Readmitted to Hospital Within 30 Days
Description
Any readmission within 30 days
Time Frame
30 days
Title
Number of Patients With Wound Infections Within 30 Days
Description
Any wound infections/complications
Time Frame
30 days

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: planned unilateral periacetabular osteotomy informed signed consent Exclusion Criteria: Chronic/ongoing (<30 days) use of glucocorticoids (except inhalation therapy) ongoing (<30 days) use of immunosuppressive therapy insulin dependent diabetes pregnancy/breastfeeding allergies toward study medication, or medication in the standard treatment surgery cannot be performed
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
kristin J Steinthorsdottir, MD
Organizational Affiliation
Rigshospitalet, Denmark
Official's Role
Principal Investigator
Facility Information:
Facility Name
Rigshospitalet
City
Copenhagen
ZIP/Postal Code
2100
Country
Denmark

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
33399374
Citation
Steinthorsdottir KJ, Awada HN, Dirks J, Sturup J, Winther NS, Kehlet H, Aasvang EK. Early postoperative recovery after peri-acetabular osteotomy: A double-blind, randomised single-centre trial of 48 vs. 8 mg dexamethasone. Eur J Anaesthesiol. 2021 Mar 1;38(Suppl 1):S41-S49. doi: 10.1097/EJA.0000000000001410.
Results Reference
derived

Learn more about this trial

High vs Low Dose Dexamethasone on Complications in the Immediate Postoperative Phase

We'll reach out to this number within 24 hrs